Latest / Wilmington News Today | 2 Min News | The Daily News Now!
First Daily PCSK9 Pill Approved | Wilmington News
FDA just approved Lipfendra, Merck’s first daily pill targeting PCSK9 to slash LDL cholesterol by up to 60% when combined with statins—offering a major breakthrough for millions who struggle with high cholesterol, especially since it’s an oral option replacing the need for shots. Early data shows it’s well-tolerated, with mild side effects, and while long-term heart attack and stroke data isn’t in yet, doctors agree: lower LDL is always better for at-risk patients. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:advertise@thednn.ai This…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.